When was RA Capital Management founded?

RA Capital Management was founded in 2004.

Where is RA Capital Management headquartered?

RA Capital Management is headquartered in Boston, MA.

What is RA Capital Management's total asset value?

RA Capital Management has around in total assets under management.

How many investments has RA Capital Management made?

RA Capital Management has made 502 investments.

What has RA Capital Management invested in?

RA Capital Management has made numerous investments in companies like SpyGlass Pharma , CellCentric , and Stylus Medicine within the Surgical Devices and Biotechnology industries.

What has RA Capital Management invested in recently?

RA Capital Management's latest investment was on 02-Jun-2025 in SpyGlass Pharma , a company within the Surgical Devices industry.

RA Capital Management investment portfolio

RA Capital Management Overview

Investor Type

Venture Capital

Status

Active

Professionals

43

Investments

502

Portfolio

131

Exits

249

RA Capital Management General Information

Company Description

Founded in 2004, RA Capital Management is a venture capital firm headquartered in Boston, Massachusetts. The firm invests in early-stage companies. The firm also employs a long/short and sector-oriented hedge fund strategy. The firm prefers to invest in healthcare and life science companies developing drugs, medical devices, services & research tools, and diagnostics sectors based in the United States and Europe. This firm is a Registered Investment Adviser (RIA).

Business Details

Website

www.racap.com

Year Founded

2004

Investor Status

Actively Seeking New Investments

Trade Association

New England Venture Capital Association (NEVCA)

Primary Investor Type

Venture Capital

Other Investor Types

Growth/Expansion

Hedge Fund

Corporate Office

200 Berkeley Street
18th Floor
Boston, MA 02116
United States

+1 (617)



RA Capital Management Investments & Acquisitions (502)

Company Name	Deal Date	Deal Type	Industry	Company Stage
SpyGlass Pharma	02-Jun-2025	Later Stage VC	Surgical Devices	Clinical Trials - General
CellCentric	19-May-2025		Biotechnology	Clinical Trials - Phase 1
Stylus Medicine	14-May-2025		Biotechnology	Generating Revenue
Jade Biosciences	28-Apr-2025		Biotechnology	Generating Revenue
Imbria Pharmaceuticals	10-Apr-2025		Drug Discovery	Clinical Trials - Phase 2
Vaxess Technologies	09-Apr-2025		Drug Discovery	Generating Revenue
Aclaris Therapeutics	25-Mar-2025		Drug Discovery	Generating Revenue/Not Profitable
Surrozen	24-Mar-2025		Drug Discovery	Pre-Clinical Trials
Curevo Vaccine	06-Mar-2025	Later Stage VC	Drug Discovery	Clinical Trials - General
Vivace Therapeutics	28-Feb-2025	Later Stage VC	Drug Discovery	Clinical Trials - Phase 3

You’re viewing 10 of 502 investments and acquisitions. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RA Capital Management Exits (249)

Company Name	Exit Date	Exit Type
Synthego	06-May-2025	Bankruptcy: Admin/Reorg
Cerebral Therapeutics	04-Apr-2025
Edgewise Therapeutics	02-Apr-2025
IDRx	21-Feb-2025
Qvella	14-Feb-2025
Sionna Therapeutics	07-Feb-2025
Metsera	31-Jan-2025
Ocelot Bio	20-Dec-2024
NewAmsterdam Pharma Company	13-Dec-2024	Public Investment 2nd Offering
Aliada Therapeutics	11-Dec-2024	Merger/Acquisition

You’re viewing 10 of 249 exits. Get the full list »

RA Capital Management Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.